SCHEMBL6614853

SCHEMBL6614853

CC(O)C(Oc1ccc2sc(-c3ccccc3)nc2c1)N1CCNCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.43
SMN1; SMN2 Q16637 6/20 0.43
NPC1 O15118 5/20 0.43
NFKB1 P19838 5/20 0.43
NFKB2 Q00653 5/20 0.43
RELA Q04206 5/20 0.43
PKM P14618 3/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
STAT1 P42224 1/20 0.41
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DYRK1A Q13627 4/20 0.38
HDAC6 Q9UBN7 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6028975 0.84 CYP3A4 (0.41) RAB9ASMN1; SMN2NPC1CYP1A2CYP3A4
SCHEMBL5746249 0.84 CYP3A4 (0.41) RAB9ASMN1; SMN2NPC1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL6260848 0.83 CYP3A4 (0.40) RAB9ASMN1; SMN2NPC1CYP1A2CYP3A4
SCHEMBL6617841 0.79 CYP3A4 (0.39) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL6259851 0.79 CYP3A4 (0.39) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL6192336 0.79 PRMT5 (0.46) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL6256455 0.78 LMNA (0.43) RAB9ASMN1; SMN2NPC1MEN1ALDH1A1
SCHEMBL6192478 0.78 ACSL1 (0.47) RAB9ASMN1; SMN2NPC1NFKB1NFKB2
SCHEMBL6614292 0.76 NR1H4 (0.43) CYP1A2CYP3A4CYP2C9
SCHEMBL6615762 0.76 CYP3A4 (0.38) RAB9ASMN1; SMN2NPC1NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406898-A1 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-04-14 EP disclosed
WO-2003008411-A1 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2003-01-30 WO disclosed